These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16626030)

  • 1. Serological diagnosis of human polyomavirus infection.
    Lundstig A; Dillner J
    Adv Exp Med Biol; 2006; 577():96-101. PubMed ID: 16626030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiology of the human polyomaviruses.
    Stolt A; Sasnauskas K; Koskela P; Lehtinen M; Dillner J
    J Gen Virol; 2003 Jun; 84(Pt 6):1499-1504. PubMed ID: 12771419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.
    Viscidi RP; Rollison DE; Viscidi E; Clayman B; Rubalcaba E; Daniel R; Major EO; Shah KV
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):278-85. PubMed ID: 12626455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
    Knowles WA; Pipkin P; Andrews N; Vyse A; Minor P; Brown DW; Miller E
    J Med Virol; 2003 Sep; 71(1):115-23. PubMed ID: 12858417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological cross reactivity between polyomavirus capsids.
    Viscidi RP; Clayman B
    Adv Exp Med Biol; 2006; 577():73-84. PubMed ID: 16626028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.
    Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pawlita M; Waterboer T; Neale RE
    J Gen Virol; 2010 Jul; 91(Pt 7):1849-53. PubMed ID: 20219899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
    Lundstig A; Eliasson L; Lehtinen M; Sasnauskas K; Koskela P; Dillner J
    J Gen Virol; 2005 Jun; 86(Pt 6):1703-1708. PubMed ID: 15914848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.
    Hamilton RS; Gravell M; Major EO
    J Clin Microbiol; 2000 Jan; 38(1):105-9. PubMed ID: 10618072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.
    Sroller V; Hamšíková E; Ludvíková V; Vochozková P; Kojzarová M; Fraiberk M; Saláková M; Morávková A; Forstová J; Němečková S
    J Med Virol; 2014 Sep; 86(9):1560-8. PubMed ID: 24214630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simian virus 40 (SV40) and human cancer: a review of the serological data.
    Shah KV; Galloway DA; Knowles WA; Viscidi RP
    Rev Med Virol; 2004; 14(4):231-9. PubMed ID: 15248251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV).
    Knowles WA
    Adv Exp Med Biol; 2006; 577():19-45. PubMed ID: 16626025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
    Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
    J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.
    Viscidi RP; Rollison DE; Sondak VK; Silver B; Messina JL; Giuliano AR; Fulp W; Ajidahun A; Rivanera D
    Clin Vaccine Immunol; 2011 Oct; 18(10):1737-43. PubMed ID: 21880855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
    Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
    J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.
    Rollison DE; Engels EA; Halsey NA; Shah KV; Viscidi RP; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):543-50. PubMed ID: 16537714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors.
    Šroller V; Hamšíková E; Ludvíková V; Musil J; Němečková Š; Saláková M
    J Med Virol; 2016 Jul; 88(7):1254-61. PubMed ID: 26630080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediagnostic circulating polyomavirus antibody levels and risk of non-Hodgkin lymphoma.
    Teras LR; Rollison DE; Pawlita M; Michel A; Blase JL; Willhauck-Fleckenstein M; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):477-80. PubMed ID: 25488906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and stability of antibodies to thirteen polyomaviruses and association with cutaneous squamous cell carcinoma: A population-based study.
    Antonsson A; Neale RE; O'Rourke P; Wockner L; Michel A; Pawlita M; Waterboer T; Green AC
    J Clin Virol; 2018 Apr; 101():34-37. PubMed ID: 29414185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of human polyomaviruses.
    Kean JM; Rao S; Wang M; Garcea RL
    PLoS Pathog; 2009 Mar; 5(3):e1000363. PubMed ID: 19325891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.